Financials
- Market Capitalization 64.39 M
- Employee 21
- Founded 2015
- CEO N/A
- Website www.inmunebio.com
- Headquarter Nevada, United States
- FIGI BBG00LW94L98
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.84
ratio cours/chiffre d'affaires
772.44
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4138 | CSBR Champions Oncology, Inc. - Common Stock | 5.00 USD | -0.40% | +0.20% | -7.24% | -25.04% | 69.47 M USD | ||
| 4146 | IBIO iBio, Inc. - Common Stock | 1.36 USD | -2.86% | -7.48% | -2.16% | -40.87% | 67.56 M USD | ||
| 4154 | PMVP PMV Pharmaceuticals, Inc. - Common Stock | 1.22 USD | -1.61% | -6.87% | +8.93% | -14.08% | 65.22 M USD | ||
| 4156 | RNTX Rein Therapeutics, Inc. - Common Stock | 0.78 USD | 0.00% | -4.88% | 0.00% | -29.11% | 67.29 M USD |